Health and Human Services Secretary Robert F. Kennedy Jr. said this week that President Trump wants an autism-vaccine investigation, confirming reporting published the previous week by The Wall Street Journal. The exchange, on CNN's "State of the Union," has pushed a question many parents thought settled back into pediatric waiting rooms weeks before the school year begins.
For families, the practical question is not who is directing federal research priorities. It is whether anything has actually changed about what is known, and whether a scheduled well-child visit should now go differently. The short answer is that the underlying evidence has not changed, the recommended schedule from pediatric professional societies has not changed, and the most useful thing a parent can do is bring the specific concern to their child's clinician rather than resolve it from a webpage.
The Body of Evidence That Already Exists
The suggestion of a vaccine and autism link originated in a 1998 paper, based on 12 children, that was later retracted after an investigation found serious ethical and methodological problems. Its lead author, Andrew Wakefield, was barred from practicing medicine in Britain. What followed was roughly two and a half decades of research designed to test the hypothesis directly.
The largest single study is a Danish nationwide cohort of 657,461 children, published in the Annals of Internal Medicine. It used national registries to link vaccination records, autism diagnoses, sibling history and other risk factors. During follow-up, 6,517 children were diagnosed with autism. The rate was the same among children who received MMR and those who did not, and the finding held for children with a sibling who had autism, a subgroup often described as genetically susceptible. The authors noted that the analysis relied on registry data rather than individual chart review.
It built on an earlier Danish cohort of 537,303 children that reached the same conclusion, and sits alongside a Cochrane review of 138 studies and a meta-analysis covering more than 1.2 million children.
The most recent independent assessment came late last year. The World Health Organization's Global Advisory Committee on Vaccine Safety reviewed two new systematic reviews. The first, covering 31 primary studies — 16 of them on thiomersal-containing vaccines — plus five meta-analyses, found no evidence of an association. Twenty of the 31 studies, including the most methodologically rigorous, found none, while the 11 suggesting a possible link had significant methodological problems and high risk of bias. The second examined aluminum adjuvants and likewise found no association. The committee reaffirmed its earlier conclusions that there is no evidence of a causal relationship between vaccines and autism spectrum disorder.
The Distinction That Causes Most of the Confusion
Two statements that sound contradictory are both accurate, and holding them together resolves much of the public confusion.
The first is that the causes of autism are not fully established. Researchers point to a substantial genetic component, prenatal factors, parental age, and broadened diagnostic criteria and improved screening that account for part of the measured rise in prevalence. Autism prevalence in the CDC's monitoring report reached one in 31 children, up from one in 36 two years earlier and one in 150 at the start of the century. Meaningful questions remain open.
The second is that vaccines have been examined thoroughly and repeatedly ruled out as a contributor. That is a narrower claim than "we know what causes autism," and it rests on a much larger evidence base.
Conflating uncertainty about causes with uncertainty about vaccines is where confusion typically starts. The CDC's vaccine safety page now states that the claim "vaccines do not cause autism" is not evidence-based because studies have not ruled out the possibility that infant vaccines cause autism. The page was revised again in recent weeks: a footnote explaining that a header had been retained under an agreement with Senator Bill Cassidy was replaced with language saying scientists have not identified the root causes of autism. The rest of the page was unchanged.
Proving a complete negative is not possible in observational epidemiology, and correlation between rising prevalence and an expanding schedule is not evidence of causation. Dozens of large studies finding no association are the strongest evidence the method allows, and it is what regulators worldwide have relied on.
Scope Limits on Any New Federal Work
A federal review can realistically examine some questions and not others. HHS has said it launched a comprehensive assessment of autism causes, including investigations of plausible biologic mechanisms and potential causal links, and the CDC has previously indicated it would use the Vaccine Safety Datalink, a system drawing on electronic health records from about a dozen health care organizations.
That system can compare autism rates by vaccine timing, by cumulative exposure and by specific product across large populations. It can add statistical power to questions about the first six months of life, which is where the federal argument has focused.
It cannot ethically randomize children to receive or not receive vaccines against serious diseases. It cannot resolve the genetic and prenatal contributors to autism, which fall outside vaccine safety surveillance entirely. And a review's credibility will depend on whether its methods are published in advance and whether its findings are independently reviewable.
Alison Singer, co-founder and president of the Autism Science Foundation, has argued that the question is asked and answered, and that spending on settled science diverts money from research into genetics and from services for autistic people. The American Academy of Pediatrics has made the same argument. That criticism concerns priorities rather than evidence.
Bringing the Question to a Pediatrician
Vaccine recommendations from pediatric professional societies have not changed as a result of federal statements or website revisions. The current AAP immunization schedule remains the reference most pediatricians follow.
A separate federal effort matters here. HHS and the CDC narrowed the routine childhood schedule from 17 diseases to 11, and a federal court stayed that revision in American Academy of Pediatrics v. Kennedy, finding it likely violated the Administrative Procedure Act and reverting the CDC schedule to its earlier version. The court also stayed 13 recent appointments to the Advisory Committee on Immunization Practices. The government has appealed, and the case remains pending — which means parents may encounter conflicting federal and specialty-society messaging at the same visit.
Parents with a specific concern will get further by naming it. Asking about a particular vaccine, a particular timing question, or a particular family history is a conversation a pediatrician can have concretely. Asking whether vaccines cause autism in general tends to produce a summary answer that satisfies no one.
Families watching for developmental differences can ask about screening at 18 and 24 months and about early intervention referrals, which are available in every state and do not require a formal diagnosis to begin. Delaying vaccination while waiting for a federal report carries a concrete risk during a year in which US measles cases have reached a 35-year high.
HHS has not announced a publication date for its assessment, and the federal appeal over the childhood schedule remains pending.
The most reliable current statement is that no credible evidence links routine childhood vaccines to autism, that the causes of autism remain an active and legitimate area of research, and that a child's own clinician is a better source than a website whose wording is itself the subject of dispute.
Related MedicalDaily Coverage
Senator Says HHS Discussed Removing Vaccine and Autism Claims from the CDC Website
Vaccine Exemptions Among U.S. Kindergartners Reach Record 3.6% as Measles Outbreaks Emerge
Measles Hospitalizations Fell This Year Even as Case Counts Hit a 35-Year High
Frequently Asked Questions
What is new here? Kennedy said publicly that the President wants him to investigate perceived links between autism and vaccines. HHS has said it launched a broad assessment of autism causes, and the CDC's vaccine safety webpage was revised again in recent weeks.
Do vaccines cause autism? No credible evidence supports a link. Large studies across multiple countries, including a Danish cohort of 657,461 children, found the same autism rates in vaccinated and unvaccinated children. A WHO expert committee reaffirmed that conclusion after reviewing 31 studies.
Has the recommended vaccine schedule changed? The current AAP schedule remains in force, and the CDC schedule still calls for two MMR doses. A federal effort to narrow the routine schedule was stayed by a court and is under appeal.
What could a new federal review actually examine? Using the Vaccine Safety Datalink, researchers can compare autism rates by vaccine timing, cumulative exposure and specific product across large populations. It cannot randomize children to go unvaccinated, and it cannot address genetic or prenatal contributors.
Why has autism prevalence increased? Researchers attribute much of the measured increase to broadened diagnostic criteria, improved screening and greater awareness, alongside genetic and prenatal factors. The CDC's most recent report found one in 31 children diagnosed, up from one in 150 at the start of the century.
What should a parent do before a well-child visit? Write down the specific concern, including which vaccine and what worries them about it, and raise it directly. Naming the concern produces a more useful conversation than a general question.
Where can families find autism information and support? Early intervention services are available in every state and can be accessed without a formal diagnosis. A pediatrician can make the referral, and developmental screening is recommended at 18 and 24 months.
